Truist Financial Issues Positive Forecast for Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price

Sabra Healthcare REIT (NASDAQ:SBRAFree Report) had its price objective hoisted by Truist Financial from $20.00 to $21.00 in a report issued on Tuesday, Marketbeat.com reports. They currently have a hold rating on the real estate investment trust’s stock.

Several other equities research analysts have also recently commented on the company. Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, October 8th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Saturday, January 3rd. UBS Group initiated coverage on Sabra Healthcare REIT in a report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 price objective for the company. National Bankshares set a $22.00 target price on shares of Sabra Healthcare REIT in a research report on Friday, October 17th. Finally, Wells Fargo & Company boosted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Four analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Sabra Healthcare REIT has an average rating of “Hold” and a consensus price target of $21.11.

Get Our Latest Stock Report on Sabra Healthcare REIT

Sabra Healthcare REIT Trading Down 0.2%

SBRA opened at $19.21 on Tuesday. Sabra Healthcare REIT has a 1-year low of $15.60 and a 1-year high of $19.97. The stock has a market capitalization of $4.79 billion, a PE ratio of 26.68, a PEG ratio of 1.17 and a beta of 0.67. The company has a current ratio of 5.19, a quick ratio of 5.19 and a debt-to-equity ratio of 0.92. The firm has a 50-day moving average price of $19.03 and a two-hundred day moving average price of $18.69.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last released its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.37 by $0.01. The business had revenue of $190.04 million for the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. Sabra Healthcare REIT’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, equities analysts anticipate that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Monday, November 17th were issued a dividend of $0.30 per share. The ex-dividend date was Monday, November 17th. This represents a $1.20 annualized dividend and a yield of 6.2%. Sabra Healthcare REIT’s payout ratio is currently 166.67%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Harbor Capital Advisors Inc. raised its stake in Sabra Healthcare REIT by 144.9% in the 4th quarter. Harbor Capital Advisors Inc. now owns 11,104 shares of the real estate investment trust’s stock valued at $210,000 after acquiring an additional 6,569 shares during the period. Aberdeen Group plc raised its position in shares of Sabra Healthcare REIT by 1.8% in the fourth quarter. Aberdeen Group plc now owns 938,098 shares of the real estate investment trust’s stock valued at $17,768,000 after purchasing an additional 16,960 shares during the period. Frank Rimerman Advisors LLC lifted its stake in shares of Sabra Healthcare REIT by 62.9% during the 4th quarter. Frank Rimerman Advisors LLC now owns 21,397 shares of the real estate investment trust’s stock worth $405,000 after buying an additional 8,258 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in shares of Sabra Healthcare REIT by 9.3% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 17,574 shares of the real estate investment trust’s stock worth $337,000 after buying an additional 1,490 shares during the period. Finally, Retirement Systems of Alabama boosted its holdings in shares of Sabra Healthcare REIT by 0.8% during the 4th quarter. Retirement Systems of Alabama now owns 1,179,360 shares of the real estate investment trust’s stock worth $22,337,000 after buying an additional 9,337 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Featured Articles

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.